Back to Market Feed

Product Information

BLEOMYCIN SULFATE 15 UNIT VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $26.4480 per EA under NDC 63323013610. Its NADAC has been published 88 times since Dec 18, 2024.

FDA first approved this application on Jan 28, 2008. Its Orange Book therapeutic-equivalence code is AP.

BLEOMYCIN SULFATE 15 UNIT VIAL

BLEOMYCIN SULFATE
$26.4480per EA

Strength

15 [USP'U]/1

NDC

63323013610

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS

Effective Date

4/22/2026

Active Ingredients

BLEOMYCIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA065185

FDA Approved

1/28/2008

TE Code

AP

On Market Since

2/13/2009

Pharmacological Classes

Cytoprotective Agent

Price Statistics

The NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has been published 88 times since Dec 18, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.

Current price$26.4480 per EA
All-time high$31.7820 (Dec 10, 2025)
All-time low$24.0040 (Dec 17, 2025)
52-week high$31.7820
52-week low$24.0040
Median price$31.7820
Average price$29.2065
Largest weekly change-24.5% (Dec 17, 2025)
Weeks tracked88
Tracking sinceDec 18, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.6%

1Y

-16.8%

3Y

N/A

5Y

N/A

All

-16.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BLEOMYCIN SULFATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BLEOMYCIN SULFATE 15 UNIT VIAL
Generic
00143924001•Hikma Pharmaceuticals USA Inc.
$26.4480
per EA
BLEOMYCIN SULFATE 15 UNIT VIAL
Generic
00409033220•Hospira Inc.
$26.4480
per EA
BLEOMYCIN SULFATE 15 UNIT VIAL
Generic
16714088601•NorthStar Rx LLC
$26.4480
per EA
BLEOMYCIN SULFATE 15 UNIT VIAL
Generic
61703033218•Hospira Inc.
$26.4480
per EA
BLEOMYCIN SULFATE 15 UNIT VIAL
Generic
71288010610•Meitheal Pharmaceuticals Inc.
$26.4480
per EA

Frequently asked questions

What is the NADAC price of BLEOMYCIN SULFATE 15 UNIT VIAL?

The current National Average Drug Acquisition Cost (NADAC) for BLEOMYCIN SULFATE 15 UNIT VIAL, manufactured by Fresenius Kabi USA, LLC, is $26.4480 per EA (NDC 63323013610), effective Aug 19, 2026.

How has the price of BLEOMYCIN SULFATE 15 UNIT VIAL changed over time?

Over the history we have for it, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has declined 16.8%. It has been tracked across 88 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for BLEOMYCIN SULFATE 15 UNIT VIAL?

Since Dec 18, 2024, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has ranged from a low of $24.0040 (Dec 17, 2025) to a high of $31.7820 (Dec 10, 2025), with a median of $31.7820 per EA.

Are there cheaper alternatives to BLEOMYCIN SULFATE 15 UNIT VIAL?

No other NADAC-published product currently shares the active ingredient and strength of BLEOMYCIN SULFATE 15 UNIT VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BLEOMYCIN SULFATE 15 UNIT VIAL?

BLEOMYCIN SULFATE 15 UNIT VIAL (NDC 63323013610) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.